Unlocking Cannabis Tax Deductions: Impacts Of 280E Repeal – Trulieve Cannabis (OTC:TCNNF), Ascend Wellness … – Benzinga


The cannabis industry may be on the verge of significant financial relief with the Biden administration’s proposal to reclassify cannabis to Schedule III of the Controlled Substances Act. This reclassification would eliminate the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical business expenses.

Potential Profit Boost From Cannabis Reclassification

The proposed rescheduling could change the landscape dramatically. According to MJBizDaily guest columnists Neil Prasad and Martin Martinez, both part of Marcum LLP, reclassification would allow cannabis companies to deduct business expenses, aligning them with businesses in other industries. This shift could lead to increased profitability through reductions in taxable income, potentially lowering prices for consumers and making medical cannabis more accessible.

Tax Changes Could Propel Cannabis Industry Growth

Moreover, as Prasad and Martinez note, if cannabis is rescheduled these companies could claim a full spectrum of business deductions, aligning their tax treatment with that of other industries. The potential for deducting ordinary business expenses would transform the economic landscape for cannabis companies, allowing for:

Reinvestment In Operations: Freed funds could be channeled back into business expansion, research and development, and innovation, driving further growth in the sector. Lower Consumer Prices: Reductions in operational costs could

Read More

Scroll to Top
Florida Dispensaries